Prognostic Factor and Serum Biomarker Changes in Non-Surgical Hepatocellular Carcinoma Patients Treated with Radioembolization
1. Abstract 1.1: Background Transarterial radioembolization (TARE) with 90Y is a primary therapy for hepatocellular carcinoma (HCC), including patients with portal vein thrombosis (PVT). Patient survival subgroups post TARE have not been clearly defined.
Surgical Management in Sacrococcygeal Pilonidal Sinus Disease Depending on The Suggested Staging System
1. Abstract 1.1. Background The optimal treatment for the sacrococcygeal pilonidal disease has not been established. Recurrence rates vary by surgical technique. Recurrence wasn’t the only factor in choosing the optimal technique. The procedure should be easy, inexpensive, have few com plications, and allow the patient to return to work or routine
